Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederick Wolfe

Showing results (181-190 of 202) with videos related to

Pageof 21
Sort By:
Seminars in Arthritis and Rheumatism|December 6, 2016
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteriaFrederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, et al.
The Journal of Rheumatology|February 3, 2011
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for FibromyalgiaFrederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, et al.
Arthritis Care & Research|May 13, 2010
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severityFrederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, et al.
Arthritis and Rheumatism|February 2, 2008
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989Grant W Cannon, Seth H Pincus, Ronald D Emkey, et al.
Clinical and Experimental Rheumatology|June 14, 2022
Concerns about the taxonomy, definition and coding of fibromyalgia syndrome in ICD-11: the potential for negative consequences for patient care and researchWinfried Häuser, Daniel J Clauw, Frederick Wolfe, et al.
American Journal of Human Genetics|December 29, 2005
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4Robert M Plenge, Leonid Padyukov, Elaine F Remmers, et al.
Arthritis and Rheumatism|May 29, 2007
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohortsHye-Soon Lee, Patricia Irigoyen, Marlena Kern, et al.
Arthritis and Rheumatism|January 1, 2008
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part IIReva C Lawrence, David T Felson, Charles G Helmick, et al.
Arthritis and Rheumatism|December 14, 2004
Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drugSteven A Mazzuca, Kenneth D Brandt, Barry P Katz, et al.
Arthritis and Rheumatism|June 30, 2005
Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trialKenneth D Brandt, Steven A Mazzuca, Barry P Katz, et al.
Pageof 21

Showing results (181-190 of 202) with videos related to

Sort By:
Pageof 21
Seminars in Arthritis and Rheumatism|December 6, 2016
2016 Revisions to the 2010/2011 fibromyalgia diagnostic criteriaFrederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, et al.
The Journal of Rheumatology|February 3, 2011
Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for FibromyalgiaFrederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, et al.
Arthritis Care & Research|May 13, 2010
The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severityFrederick Wolfe, Daniel J Clauw, Mary-Ann Fitzcharles, et al.
Arthritis and Rheumatism|February 2, 2008
Double-blind trial of recombinant gamma-interferon versus placebo in the treatment of rheumatoid arthritis. 1989Grant W Cannon, Seth H Pincus, Ronald D Emkey, et al.
Clinical and Experimental Rheumatology|June 14, 2022
Concerns about the taxonomy, definition and coding of fibromyalgia syndrome in ICD-11: the potential for negative consequences for patient care and researchWinfried Häuser, Daniel J Clauw, Frederick Wolfe, et al.
American Journal of Human Genetics|December 29, 2005
Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4Robert M Plenge, Leonid Padyukov, Elaine F Remmers, et al.
Arthritis and Rheumatism|May 29, 2007
Interaction between smoking, the shared epitope, and anti-cyclic citrullinated peptide: a mixed picture in three large North American rheumatoid arthritis cohortsHye-Soon Lee, Patricia Irigoyen, Marlena Kern, et al.
Arthritis and Rheumatism|January 1, 2008
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part IIReva C Lawrence, David T Felson, Charles G Helmick, et al.
Arthritis and Rheumatism|December 14, 2004
Subject retention and adherence in a randomized placebo-controlled trial of a disease-modifying osteoarthritis drugSteven A Mazzuca, Kenneth D Brandt, Barry P Katz, et al.
Arthritis and Rheumatism|June 30, 2005
Effects of doxycycline on progression of osteoarthritis: results of a randomized, placebo-controlled, double-blind trialKenneth D Brandt, Steven A Mazzuca, Barry P Katz, et al.
Pageof 21